Yidan Liu
State Key Laboratory Of Ophthalmology, Guangdong Provincial Key Laboratory Of Ophthalmology And Visual Science
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Metal ions in aging and ocular diseases: biology, pathophysiology, and therapeutic strategies.
Journal: npj aging
Published: December 09, 2025
St6gal1-mediated sialylation protects retinal ganglion cells by restraining microglial phagocytosis.
St6gal1-mediated sialylation protects retinal ganglion cells by restraining microglial phagocytosis.
Journal: Journal of neuroinflammation
Published: November 25, 2025
Heterochronic parabiosis uncovers AdipoR1 as a critical player in retinal rejuvenation.
Journal: Science advances
Published: July 16, 2025
New Insights into the Role of Cellular Senescence and Its Therapeutic Implications in Ocular Diseases.
Journal: Bioengineering (Basel, Switzerland)
Published: March 26, 2025
Correction: Progesterone attenuates Th17-cell pathogenicity in autoimmune uveitis via Id2/Pim1 axis.
Correction: Progesterone attenuates Th17-cell pathogenicity in autoimmune uveitis via Id2/Pim1 axis.
Journal: Journal of neuroinflammation
Published: March 06, 2025
Single-cell profiling unveils a geroprotective role of Procyanidin C1 in hematopoietic immune system via senolytic and senomorphic effects.
Journal: npj aging
Published: December 19, 2024
Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6/ID2 axis.
Journal: Journal of advanced research
Published: May 03, 2024
Senolytic and senomorphic agent procyanidin C1 alleviates structural and functional decline in the aged retina.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 24, 2024
Kurarinone regulates Th17/Treg balance and ameliorates autoimmune uveitis via Rac1 inhibition.
Journal: Journal of advanced research
Published: October 26, 2023
Empagliflozin targets Mfn1 and Opa1 to attenuate microglia-mediated neuroinflammation in retinal ischemia and reperfusion injury.
Journal: Journal of neuroinflammation
Published: October 17, 2023
Last Updated: 09/26/2026